Bo Liu

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

High Efficiency

Ultra High Performance Liquid Chromatography

Top Venues

Chemical communications (Cambridge, England)

Rapid communications in mass spectrometry : RCM

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Chunxia Yin, Taohua Lan, Yunshan Wu, Jing Cai, Haoxiang Li, Xiaolan Kuang, Lin Jiao, Xiaomin Ou, Hua Yang, Bo Liu, Weihui Lu
Integrating Network Pharmacology and Experimental Validation to Investigate the Mechanism of Qushi Huatan Decoction Against Coronary Heart Disease. Drug design, development and therapy 18 (2024)
Xuan Wang, Jianlong Li, Haifang Du, Weihong Liang, Cheng Luo, Yunshan Wu, Bo Liu
Synthesis of 1,4-epoxy-2-aryltetrahydro-1-benzazepines via rhodium(III)-catalyzed C-H allylation/intramolecular 1,3-dipolar cycloaddition. Chemical communications (Cambridge, England) (2024)
Xuan Wang, Jianlong Li, Haifang Du, Weihong Liang, Cheng Luo, Yunshan Wu, Bo Liu
Synthesis of 1,4-epoxy-2-aryltetrahydro-1-benzazepines via rhodium(III)-catalyzed C-H allylation/intramolecular 1,3-dipolar cycloaddition. Chemical communications (Cambridge, England) 60 (17) (2024)
Li-Lan Wu, Yun-Shan Wu, Wei-Ying Chen, Wen Zhou, Lipeng Tang, Ben Li, Bo Liu
Determination of artemisitene in rat plasma by ultra-performance liquid chromatography/tandem mass spectrometry and its application in pharmacokinetics. Rapid communications in mass spectrometry : RCM 31 (13) (2018)